scholarly journals A case of secondary adrenocortical insufficiency due to isolated adrenocorticotropic hormone deficiency with empty sella syndrome after pembrolizumab treatment in a patient with metastatic renal pelvic cancer

2021 ◽  
pp. 101766
Author(s):  
Takashi Nagai ◽  
Tohru Mogami ◽  
Tomoki Takeda ◽  
Nami Tomiyama ◽  
Takahiro Yasui
1986 ◽  
Vol 75 (3) ◽  
pp. 414-419 ◽  
Author(s):  
Eisuke TAKAZAKURA ◽  
Yasuhito TERADA ◽  
Hiroshi MAKINO ◽  
Harumi OKI ◽  
Jinichiro HIROSE

1995 ◽  
Vol 34 (7) ◽  
pp. 688-691 ◽  
Author(s):  
Toshimitsu HATAZOE ◽  
Yoshio MURAKAMI ◽  
Itsumi UMAKI ◽  
Motoi SOHMIYA ◽  
Hong-Yi Hu ◽  
...  

2021 ◽  
Vol 14 (7) ◽  
pp. e243093
Author(s):  
Koichi Hata ◽  
Chikara Sakaguchi ◽  
Michiko Tsuchiya ◽  
Yukio Nagasaka

Used for a wide range of cancers, nivolumab has been reported to cause immune-related adverse events, including isolated adrenocorticotropic hormone deficiency (IAD). We report an 81-year-old woman with malignant mesothelioma who presented with abdominal pain after eight courses of nivolumab therapy, leading to the diagnosis of nivolumab-induced IAD. We should consider adrenal insufficiency (AI) when a patient on nivolumab complains of abdominal pain and has no other explanatory findings. Infusion-resistant hypotension and hyponatraemia can further suggest AI.


2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Ayumu Takeno ◽  
Masahiro Yamamoto ◽  
Miwa Morita ◽  
Sayuri Tanaka ◽  
Ippei Kanazawa ◽  
...  

2014 ◽  
Vol 8 (1) ◽  
Author(s):  
Jun Kinoshita ◽  
Shinnosuke Higashino ◽  
Sachio Fushida ◽  
Katsunobu Oyama ◽  
Toshifumi Watanabe ◽  
...  

Pituitary ◽  
2018 ◽  
Vol 21 (5) ◽  
pp. 480-489 ◽  
Author(s):  
Hironori Bando ◽  
Genzo Iguchi ◽  
Keitaro Kanie ◽  
Hitoshi Nishizawa ◽  
Ryusaku Matsumoto ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document